On this health series episode of NCL’s “We Can Do this” podcast, Director of Health Policy, Robin Strongin, sits with Sarah Ikenberry, Senior Communication Advisor for the Office of Therapeutic Biologics and Biosimilars at US Food and Drug Administration, and Julie Reed, Executive Director of the Biosimilars Forum. In this podcast, Robin, Sarah and Julie discuss what biosimilars are, what they mean for patients and how biosimilars can be a cost-saving alternative for patients. 

For more information on biosimilars, visit https://scriptyourfuture.org/biosimilars/.